Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas

被引:88
作者
Gérard, AC
Daumerie, C
Mestdagh, C
Gohy, S
de Burbure, C
Costagliola, S
Miot, F
Nollevaux, MC
Denef, JF
Rahier, J
Franc, B
De Vijlder, JJM
Colin, IM
Many, MC
机构
[1] Catholic Univ Louvain, Sch Med, Histol Unit, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Sch Med, Endocrinol Unit, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, Sch Med, Pathol Unit, B-1200 Brussels, Belgium
[4] Free Univ Brussels, Inst Rech Interdisciplinaire, B-1070 Brussels, Belgium
[5] Hop Ambroise Pare, Serv Anat & Cytol Pathol, F-912100 Boulogne, France
[6] Univ Amsterdam, Acad Med Ctr, NL-1012 Amsterdam, Netherlands
关键词
D O I
10.1210/jc.2003-030586
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Progress in biotechnology has provided useful tools for tracing proteins involved in thyroid hormone synthesis in vivo. Mono- or polyclonal antibodies are now available to detect on histological sections the Na+/I- symporter (NIS) at the basolateral pole of the cell, the putative iodide channel (pendrin) at the apical plasma membrane, thyroperoxidase (TPO), and members of the NADPH-oxidase family, thyroid oxidase 1 and 2 (ThOXs), part of the H2O2-generating system. The aim of this study was to correlate thyroglobulin (Tg) iodination with the presence of these proteins. Tg, T-4-containing Tg, NIS, pendrin, TPO, ThOXs, and TSH receptor (TSHr) were detected by immunohistochemistry on tissue sections of normal thyroids and various benign and malignant thyroid disorders. Tg was present in all cases. T-4-containing Tg was found in the adenomas, except in Hurthle cell adenomas. It was never detected in carcinomas. NIS was reduced in all types of carcinomas, whereas it was detected in noncancerous tissues. Pendrin was not expressed in carcinomas, except in follicular carcinomas, where weak staining persisted. TPO expression was present in insular, follicular carcinomas and in follicular variants of papillary carcinomas, but in a reduced percentage of cells. It was below the level of detection in papillary carcinomas. The H2O2-generating system, ThOXs, was found in all carcinomas and was even increased in papillary carcinomas. Its staining was apical in normal thyroids, whereas it was cytoplasmic in carcinomas. The TSHr was expressed in all cases, but the intensity of the staining was decreased in insular carcinomas. In conclusion, our work shows that all types of carcinomas lose the capacity to synthesize T-4-rich, iodinated Tg. In follicular carcinomas, this might be due to a defect in iodide transport at the basolateral pole of the cell. In papillary carcinomas, this defect seems to be coupled to an altered apical transport of iodide and probably TPO activity. The TSHr persists in virtually all cases.
引用
收藏
页码:4977 / 4983
页数:7
相关论文
共 44 条
  • [1] Aogi K, 1998, CLIN CANCER RES, V4, P1965
  • [2] Expression of pendrin and the Pendred Syndrome (PDS) gene in human thyroid tissues
    Bidart, JM
    Mian, C
    Lazar, V
    Russo, D
    Filetti, S
    Caillou, B
    Schlumberger, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) : 2028 - 2033
  • [3] Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
    Bunone, G
    Vigneri, P
    Mariani, L
    Butó, S
    Collini, P
    Pilotti, S
    Pierotti, MA
    Bongarzone, I
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) : 1967 - 1976
  • [4] Na+/I- symporter distribution in human thyroid tissues:: An immunohistochemical study
    Caillou, B
    Troalen, F
    Baudin, E
    Talbot, M
    Filetti, S
    Schlumberger, M
    Bidart, JM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11) : 4102 - 4106
  • [5] IODIDE TRANSPORT IN THE THYROID-GLAND
    CARRASCO, N
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1154 (01) : 65 - 82
  • [6] Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer
    Castro, MR
    Bergert, ER
    Beito, TG
    Roche, PC
    Ziesmer, SC
    Jhiang, SM
    Goellner, JR
    Morris, JC
    [J]. JOURNAL OF ENDOCRINOLOGY, 1999, 163 (03) : 495 - 504
  • [7] Chiappetta G, 1998, CANCER RES, V58, P4193
  • [8] Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer?
    Czarnocka, B
    Pastuszko, D
    Janota-Bzowski, M
    Weetman, AP
    Watson, PF
    Kemp, EH
    McIntosh, RS
    Asghar, MS
    Jarzab, B
    Gubala, E
    Wloch, J
    Lange, D
    [J]. BRITISH JOURNAL OF CANCER, 2001, 85 (06) : 875 - 880
  • [9] Cloning and characterization of the thyroid iodide transporter
    Dai, G
    Levy, O
    Carrasco, N
    [J]. NATURE, 1996, 379 (6564) : 458 - 460
  • [10] Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family
    De Deken, X
    Wang, DT
    Many, MC
    Costagliola, S
    Libert, F
    Vassart, G
    Dumont, JE
    Miot, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (30) : 23227 - 23233